论文部分内容阅读
对20例慢性肝病合并胆系感染病人进行了临床疗效、微循环及血液流变学观察,证明该药对合并慢性胆囊胆管炎、胆囊炎、胆管炎的慢性肝病病人疗效满意,可改善其微循环指标,控制胆系感染,促进肝脏病变恢复。
Clinical efficacy, microcirculation and hemorheology were observed in 20 patients with chronic liver disease complicated with biliary tract infection. The results showed that the drug was effective in patients with chronic liver disease complicated with chronic cholecystitis, cholecystitis and cholangitis, Cycle indicators, control of biliary infection, promote liver disease recovery.